PRESS RELEASE published on 10/04/2023 at 13:00, 2 years 5 months ago Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
PRESS RELEASE published on 09/30/2023 at 01:37, 2 years 5 months ago Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/14/2023 at 16:15, 2 years 6 months ago EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
PRESS RELEASE published on 09/13/2023 at 12:30, 2 years 6 months ago Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
PRESS RELEASE published on 09/11/2023 at 19:53, 2 years 6 months ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
PRESS RELEASE published on 09/11/2023 at 13:00, 2 years 6 months ago Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics
PRESS RELEASE published on 09/08/2023 at 22:37, 2 years 6 months ago Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
PRESS RELEASE published on 09/06/2023 at 22:30, 2 years 6 months ago Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
PRESS RELEASE published on 09/06/2023 at 13:00, 2 years 6 months ago Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
PRESS RELEASE published on 08/30/2023 at 13:00, 2 years 6 months ago Moderna to Host Investor Event - R&D Day and Business Updates
Published on 03/27/2026 at 12:30, 1 hour 45 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 2 hours 15 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 3 hours 15 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 4 hours 45 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 13:30, 45 minutes ago Weiqiao Pioneering Group Adds Sixth National 'Green Factory'
Published on 03/27/2026 at 13:30, 45 minutes ago Weiqiao Chuangye : le groupe compte désormais six sites labellisés « usine verte » nationale
Published on 03/27/2026 at 13:00, 1 hour 15 minutes ago NR21: Mise à disposition du Rapport financier annuel 2025
Published on 03/27/2026 at 11:45, 2 hours 30 minutes ago Second National Showcase of Outstanding Works from China’s Rare Operatic Genres Held
Published on 03/27/2026 at 07:00, 7 hours 15 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 19 hours 58 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 19 hours 58 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 20 hours 15 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
